BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 36588107)

  • 1. Targeting integrin pathways: mechanisms and advances in therapy.
    Pang X; He X; Qiu Z; Zhang H; Xie R; Liu Z; Gu Y; Zhao N; Xiang Q; Cui Y
    Signal Transduct Target Ther; 2023 Jan; 8(1):1. PubMed ID: 36588107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin targeted therapeutics.
    Millard M; Odde S; Neamati N
    Theranostics; 2011 Feb; 1():154-88. PubMed ID: 21547158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrins in cell adhesion and signaling.
    Akiyama SK
    Hum Cell; 1996 Sep; 9(3):181-6. PubMed ID: 9183647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials.
    Gu Y; Dong B; He X; Qiu Z; Zhang J; Zhang M; Liu H; Pang X; Cui Y
    Pharmacol Res; 2023 Mar; 189():106694. PubMed ID: 36775082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrins as therapeutic targets.
    Goodman SL; Picard M
    Trends Pharmacol Sci; 2012 Jul; 33(7):405-12. PubMed ID: 22633092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of integrins in cancer: survey of expression patterns.
    Mizejewski GJ
    Proc Soc Exp Biol Med; 1999 Nov; 222(2):124-38. PubMed ID: 10564536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin.
    Lele M; Sajid M; Wajih N; Stouffer GA
    Circulation; 2001 Jul; 104(5):582-7. PubMed ID: 11479257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the Matrix: The Many Non-ECM Ligands for Integrins.
    LaFoya B; Munroe JA; Miyamoto A; Detweiler MA; Crow JJ; Gazdik T; Albig AR
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
    Leclerc JR
    Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrins Within the Tumor Microenvironment: Biological Functions, Importance for Molecular Targeting, and Cancer Therapeutics Innovation.
    Dzobo K
    OMICS; 2021 Jul; 25(7):417-430. PubMed ID: 34191612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disintegrins: integrin selective ligands which activate integrin-coupled signaling and modulate leukocyte functions.
    Barja-Fidalgo C; Coelho AL; Saldanha-Gama R; Helal-Neto E; Mariano-Oliveira A; Freitas MS
    Braz J Med Biol Res; 2005 Oct; 38(10):1513-20. PubMed ID: 16172744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin structure.
    Humphries MJ
    Biochem Soc Trans; 2000; 28(4):311-39. PubMed ID: 10961914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrins regulate stemness in solid tumor: an emerging therapeutic target.
    Xiong J; Yan L; Zou C; Wang K; Chen M; Xu B; Zhou Z; Zhang D
    J Hematol Oncol; 2021 Oct; 14(1):177. PubMed ID: 34715893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy.
    Ellert-Miklaszewska A; Poleszak K; Pasierbinska M; Kaminska B
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrins: role in cell adhesion and communication.
    Gille J; Swerlick RA
    Ann N Y Acad Sci; 1996 Oct; 797():93-106. PubMed ID: 8993354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Integrins for Cancer Therapy - Disappointments and Opportunities.
    Bergonzini C; Kroese K; Zweemer AJM; Danen EHJ
    Front Cell Dev Biol; 2022; 10():863850. PubMed ID: 35356286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease.
    Woodside DG; Vanderslice P
    BioDrugs; 2008; 22(2):85-100. PubMed ID: 18345706
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.